Maja Stojiljković - Genetic Mutations

Author Information

Maja Stojiljković is a researcher affiliated with the Institute of Molecular Genetics and Genetic Engineering at the University of Belgrade, located at Vojvode Stepe 444a, 11010 Belgrade, Serbia. Her research primarily focuses on genetics and molecular biology, with specific interest in genetic disorders and pharmacogenomics.

Research Contributions

Maja Stojiljković has made significant contributions to the field of genetics, particularly in the areas of congenital adrenal hyperplasia, primary ciliary dyskinesia, phenylketonuria, and the pharmacogenomics landscape related to COVID-19. Her work includes the identification and classification of novel genetic variants, the impact of genetic modifiers on untreated PKU patients, and the development of methodologies for genetic analysis such as next-generation sequencing. Her recent studies have also explored the genetic factors influencing the response to COVID-19 therapies.

Aliases

Maja Stojiljković is also known by several aliases, including M Stojiljkovic, M Stojiljković, and M. Stojiljkovic.

Publication and Citation Metrics

Metric	Value
Citation Count	1124
h-index	19
Paper Count	63

Publications:

A novel 9 bp deletion (c.1271_1279delGTGCCCGCG) in exon 10 of CYP21A2 gene causing severe congenital adrenal hyperplasia

DOI: 10.1007/s12020-021-02680-7

Year: 2021

Planar printed electrodes for electroporation with high EM field homogeneity

DOI: 10.1088/1361-6463/ac2448

Year: 2021

Identification and Classification of Novel Genetic Variants: En Route to the Diagnosis of Primary Ciliary Dyskinesia

DOI: 10.3390/ijms22168821

Year: 2021

Untreated PKU patients without intellectual disability: SHANK gene family as a candidate modifier

DOI: 10.1016/j.ymgmr.2021.100822

Year: 2021

Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations.

DOI: 10.5937/jomb0-26725

Year: 2020

List of Contributors

DOI: 10.1016/b978-0-12-816664-2.00021-9

Year: 2020

Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection

DOI: 10.1016/j.meegid.2020.104498

Year: 2020

Next-Generation Sequencing: The Enabler and the Way Ahead

DOI: 10.1016/b978-0-12-816664-2.00009-8

Year: 2020

Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection

DOI: 10.1101/2020.05.13.093690

Year: 2020

The Genetic Landscape and Epidemiology of Phenylketonuria.

DOI: 10.1016/j.ajhg.2020.06.006

Year: 2020

How is Sickle Cell Disease Diagnosed?

How is Gene Amplification Detected?

How Do Genetic Mutations Affect Agriculture?

Are There Any Risks Associated with Beneficial Mutations?

What Challenges Remain?

What is Pharmacogenomics?

What are the Latest Diagnostic Tools?

What are Inversions?

What is Genetic Diversity?

How is Sickle Cell Anemia Inherited?

Partnered Content Networks

Relevant Topics